These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26527032)

  • 1. ATAD2 is overexpressed in gastric cancer and serves as an independent poor prognostic biomarker.
    Zhang M; Zhang C; Du W; Yang X; Chen Z
    Clin Transl Oncol; 2016 Aug; 18(8):776-81. PubMed ID: 26527032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Ras-GTPase-activating protein SH3 domain-binding protein 1 correlates with poor prognosis in gastric cancer patients.
    Min L; Ruan Y; Shen Z; Jia D; Wang X; Zhao J; Sun Y; Gu J
    Histopathology; 2015 Nov; 67(5):677-88. PubMed ID: 25809930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATAD2 overexpression is associated with progression and prognosis in colorectal cancer.
    Hou M; Huang R; Song Y; Feng D; Jiang Y; Liu M
    Jpn J Clin Oncol; 2016 Mar; 46(3):222-7. PubMed ID: 26819280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of SEMA3A is associated with poor prognosis in gastric carcinoma.
    Tang C; Gao X; Liu H; Jiang T; Zhai X
    Int J Clin Exp Pathol; 2014; 7(8):4782-94. PubMed ID: 25197349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
    Guo J; Zu G; Zhou T; Xing J; Wang Z
    Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inorganic pyrophosphatase (PPA1) is a negative prognostic marker for human gastric cancer.
    Yang Y; Cai J; Yin J; Wang D; Bai Z; Zhang J; Wang K; Yu G; Zhang Z
    Int J Clin Exp Pathol; 2015; 8(10):12482-90. PubMed ID: 26722435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.
    Wang CY; Hua L; Yao KH; Chen JT; Zhang JJ; Hu JH
    Int J Clin Exp Pathol; 2015; 8(1):779-85. PubMed ID: 25755774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low level of FOXL1 indicates a worse prognosis for gastric cancer patients.
    Ertao Z; Jianhui C; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C; Hui W
    Tumour Biol; 2016 Aug; 37(8):11331-7. PubMed ID: 26960689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
    Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
    Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy.
    Aydin D; Bilici A; Kayahan S; Yavuzer D; Basar M; Aliustaoglu M
    Clin Transl Oncol; 2016 Jun; 18(6):608-16. PubMed ID: 26459248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogene ATAD2 promotes cell proliferation, invasion and migration in cervical cancer.
    Zheng L; Li T; Zhang Y; Guo Y; Yao J; Dou L; Guo K
    Oncol Rep; 2015 May; 33(5):2337-44. PubMed ID: 25813398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of ECT2 is associated with poor prognosis in gastric cancer patients.
    Jin Y; Yu Y; Shao Q; Ma Y; Zhang R; Yao H; Xu Y
    Int J Clin Exp Pathol; 2014; 7(12):8724-31. PubMed ID: 25674238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
    Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
    Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients.
    Hu X; Huang Z; Liao Z; He C; Fang X
    Int J Clin Exp Pathol; 2014; 7(10):6716-24. PubMed ID: 25400751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased Muc5AC expression is associated with poor prognosis in gastric cancer.
    Kim SM; Kwon CH; Shin N; Park DY; Moon HJ; Kim GH; Jeon TY
    Int J Cancer; 2014 Jan; 134(1):114-24. PubMed ID: 23801416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear overexpression of the overexpressed in lung cancer 1 predicts worse prognosis in gastric adenocarcinoma.
    Wang J; Shen H; Fu G; Zhao D; Wang W
    Oncotarget; 2017 Feb; 8(6):9442-9450. PubMed ID: 28038462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cadherin 5 expression correlates with poor survival in human gastric cancer.
    Higuchi K; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T
    J Clin Pathol; 2017 Mar; 70(3):217-221. PubMed ID: 27466381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and prognostic significance of C/EBP homologous protein (CHOP) in advanced gastric cancer.
    Zhang X; Zhou T; Li W; Zhang T; Che N; Zu G
    Pathol Res Pract; 2018 Aug; 214(8):1105-1109. PubMed ID: 29910063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
    He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L
    J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.